Earnings call transcript: Aviva posts strong H1 2026 profit growth as Direct Line pays off

Aviva reported 1H 2026 operating profit up 24% to GBP 1.3 billion, with operating EPS up 10% and IFRS return on equity at 20.3% (above its 20% target). Cash remittances rose 47% to GBP 1.5 billion and wealth net flows climbed 32% to GBP 7.6 billion, while the Direct Line integration is already improving written combined ratios by 10+ points. The stock was flat at $105, but Aviva reaffirmed/targets ~11% full-year 2026 operating EPS growth and guided solvency into the high 180s by year-end alongside a 7% higher interim dividend to 14 pence/share and completion of its buyback.

Analysis

The market’s muted reaction matters more than the beat: this looks like an execution story that is still not fully being capitalized in the multiple. The real mechanism is not just earnings growth, but the shift to a higher-quality capital-light mix plus balance-sheet repair, which should lower the equity risk premium if management proves the solvency path and keeps returning cash. Second-order losers are the smaller UK personal-lines players and brokers that do not have Aviva’s data breadth or integrated claims/repair stack; as pricing discipline hardens, they should lose share or accept worse combined ratios.

The main risk is that the reported strength is partly a recycling story rather than pure underlying operating leverage. If Q3 Canada weather, large losses, or reserve rebuild noise offset the promised capital progression, the rerating stalls quickly; the next 1-3 month catalyst is the year-end solvency trajectory, not this half’s headline EPS. The 6-18 month debate is whether AI and cross-sell can actually reduce acquisition cost and expense ratio enough to sustain double-digit EPS growth without needing more M&A.

Consensus appears to be underestimating how much the Direct Line integration can change the franchise, not just the near-term synergies but the data flywheel across pricing, claims, and wealth cross-sell. The more contrarian point is that the stock may still be cheap if the high-180s solvency target is delivered, because capital returns can reaccelerate; conversely, if that target slips, the market will likely treat the current improvement as cyclical and de-rate it back toward a cash-yield story.

Key Decisions for Investors

• Buy AVVIY on any 2-3% pullback over the next 1-2 weeks; initial 3-6 month target is a rerate toward the upper half of the 52-week range if solvency trends higher and guidance is reiterated.
• Express the upside with AVVIY Jan-2027 105/130 call spreads; the trade captures the capital-return and integration catalysts while limiting downside if weather or reserve noise delays the rerating.
• Set a falsifier: if the year-end solvency path does not move clearly toward the high-180s or if combined ratio guidance deteriorates above 95 in the next update, reduce exposure.
• Trim or avoid adding after any spike on the results, because the near-term upside depends on confirmation of Direct Line synergies rather than another quarter of headline earnings strength.